Erbitux and White blood cell count decreased - from FDA reports


Summary

White blood cell count decreased is found among people who take Erbitux, especially for people who are male, 60+ old , have been taking the drug for < 1 month, also take medication Cisplatin, and have Lung cancer - non-small cell. This review analyzes which people have White blood cell count decreased with Erbitux. It is created by eHealthMe based on reports of 13,598 people who have side effects when taking Erbitux from FDA , and is updated regularly.

What to expect?

If you take Erbitux and have White blood cell count decreased, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Erbitux and have White blood cell count decreased

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 04, 2017

13,598 people reported to have side effects when taking Erbitux.
Among them, 277 people (2.04%) have White blood cell count decreased


Number of reports submitted per year:

Could Erbitux cause White blood cell count decreased?

Time on Erbitux when people have White blood cell count decreased *:

  • < 1 month: 66.19 %
  • 1 - 6 months: 30.94 %
  • 6 - 12 months: 1.44 %
  • 1 - 2 years: 1.44 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have White blood cell count decreased when taking Erbitux *:

  • female: 28.62 %
  • male: 71.38 %

Age of people who have White blood cell count decreased when taking Erbitux *:

  • 0-1: 0.0 %
  • 2-9: 0.78 %
  • 10-19: 0.39 %
  • 20-29: 0.0 %
  • 30-39: 0.78 %
  • 40-49: 3.1 %
  • 50-59: 23.26 %
  • 60+: 71.71 %

Top conditions involved for these people *:

  • Lung Cancer - Non-Small Cell (30 people, 10.83%)
  • Colon Cancer (28 people, 10.11%)
  • Oral Cancer (25 people, 9.03%)
  • Rectal Cancer (20 people, 7.22%)
  • Oesophageal Adenocarcinoma (16 people, 5.78%)

Top co-used drugs for these people *:

  • Cisplatin (89 people, 32.13%)
  • Taxol (74 people, 26.71%)
  • Carboplatin (57 people, 20.58%)
  • Decadron (28 people, 10.11%)
  • Polaramine (19 people, 6.86%)

Top other side effects for these people *:

  • Neutrophil Count Decreased (95 people, 34.30%)
  • Thrombocytopenia (94 people, 33.94%)
  • Nausea (57 people, 20.58%)
  • Dehydration (57 people, 20.58%)
  • Diarrhea (50 people, 18.05%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have White blood cell count decreased when taking Erbitux?

Expand the study to include all drugs with the same ingredients

White blood cell count decreased and drugs with ingredients of cetuximab.

Expand the study to include reports from both FDA and eHealthMe

White blood cell count decreased and Erbitux from FDA and eHealthMe reports

Erbitux

Erbitux has active ingredients of cetuximab. It is often used in cancer. (latest outcomes from Erbitux 13,644 users)

White blood cell count decreased

White blood cell count decreased has been reported by people with hepatitis c, multiple myeloma, multiple sclerosis, schizophrenia, rheumatoid arthritis (latest reports from 60,316 White blood cell count decreased patients).

Browse all side effects of Erbitux

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with White blood cell count decreased

White blood cell count decreased

Could your condition cause White blood cell count decreased

White blood cell count decreased

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Erbitux and have White blood cell count decreased.

User reviews to the study

More reviews >